What is the appropriate management of a human bite wound with broken skin in an HIV‑positive patient?

Management of Human Bite with Broken Skin in HIV-Positive Individual

Immediately initiate preemptive antimicrobial therapy with amoxicillin-clavulanate 875/125 mg twice daily for 3-5 days, perform thorough wound irrigation and debridement without primary closure (except facial wounds), update tetanus prophylaxis, and assess the need for HIV post-exposure prophylaxis (PEP) for the person who was bitten if the HIV-positive individual has detectable viral load or bleeding oral lesions. 1

Antibiotic Management

The IDSA guidelines specifically recommend preemptive antimicrobial therapy for human bites with broken skin, as these wounds carry high infection risk due to complex polymicrobial flora 1. Human bite wounds contain aerobic bacteria (streptococci, S. aureus, Eikenella corrodens) and multiple anaerobes (Fusobacterium, Prevotella, Porphyromonas species).

First-line antibiotic choice:

• Oral: Amoxicillin-clavulanate 875/125 mg twice daily 1
• IV (if severe): Ampicillin-sulbactam 1.5-3.0 g every 6 hours 1

For β-lactam allergy:

• Moxifloxacin 400 mg daily (covers both aerobes and anaerobes as monotherapy), OR
• Ciprofloxacin 500-750 mg twice daily PLUS metronidazole 500 mg three times daily 1

Critical point: Eikenella corrodens (common in human bites) is resistant to first-generation cephalosporins, macrolides, clindamycin, and aminoglycosides, making amoxicillin-clavulanate the optimal choice 1.

Wound Management

Do NOT perform primary closure of human bite wounds except for facial wounds 1. The evidence strongly supports:

• Copious irrigation with sterile saline
• Cautious debridement of devitalized tissue
• Wound approximation only (not tight closure) for non-facial wounds 1
• Facial wounds: May be closed after thorough irrigation and debridement with concurrent preemptive antibiotics 1

Primary closure of human bites significantly increases infection risk, particularly for hand wounds which have higher infection rates than other locations 1.

Tetanus Prophylaxis

Administer tetanus prophylaxis based on vaccination history 1:

• If >10 years since last dose for "clean" wounds
• If >5 years since last dose for "dirty" wounds (human bites qualify)
• Tdap is preferred over Td if patient has not previously received Tdap 1

HIV Transmission Risk Assessment

This is a bidirectional concern in this scenario:

Risk TO the bitten person (if bitten BY the HIV-positive individual):

HIV transmission via human bite is rare but documented 2, 3. The 2020 case report and literature review identified specific high-risk features 2:

High-risk factors for HIV transmission:

• Deep bleeding bite wound (primary risk factor)
• High HIV plasma viral load in the biter
• Bleeding oral lesions in the HIV-positive person's mouth
• Blood-contaminated saliva 4, 2

HIV PEP should be considered if:

• The bite caused a bleeding wound AND
• The HIV-positive individual has detectable viral load or bleeding oral lesions 4, 2

The CDC guidelines note that saliva contaminated with blood poses substantial exposure risk, while uncontaminated saliva contains HIV in much lower titers and constitutes negligible risk 4.

If PEP is indicated:

• Must be initiated within 72 hours (ideally within 48 hours) 4
• 28-day course of HAART is recommended 4
• Sooner administration = higher likelihood of preventing transmission 4

Risk FROM the bitten person:

If the HIV-positive individual was the biter (not the bitten), assess for oral mucosal breaks that contacted the victim's blood, though this represents lower transmission risk 4.

Special Considerations for Immunocompromised Status

The HIV-positive status of the patient makes them high-risk for wound infection complications 1. The IDSA guidelines specifically list immunocompromised status as an indication for preemptive antimicrobial therapy 1.

Monitor closely for:

• Rapid progression to necrotizing fasciitis (can occur within 24 hours even in young patients) 5
• Systemic complications: lymphangitis, septic arthritis, tenosynovitis, osteomyelitis 6, 7
• Rare but serious: endocarditis, meningitis, brain abscess, sepsis 6, 7

Common Pitfalls to Avoid

1. Missing PEP window: If the HIV-positive person bit someone else, PEP must be offered within 72 hours 2
2. Inadequate antibiotic coverage: Avoid clindamycin or first-generation cephalosporins as monotherapy (miss Eikenella) 1
3. Primary wound closure: Increases infection risk dramatically except for facial wounds with proper preparation 1
4. Delayed recognition of necrotizing infection: Human bites can progress to life-threatening necrotizing fasciitis within 24 hours 5

Follow-up

• Re-evaluate wound within 24-48 hours for signs of infection
• Signs requiring immediate attention: rapidly spreading erythema, crepitus, systemic toxicity, severe pain out of proportion
• Complete full antibiotic course even if wound appears to be healing well